Concepedia

Yong‐Mo Ahn

YA

6

Publications

140

Citations

6

H-Index

2012

Active since

Affiliations

National Institutes of Health(Current)

Hackensack Meridian Health

Rutgers, The State University of New Jersey

Center for Discovery

Rutgers New Jersey Medical School

Yong‐Mo Ahn is an author at National Institutes of Health specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2012–2022

6

Publications

6

A sulfoximine-based inhibitor of human asparagine synthetase kills l-asparaginase-resistant leukemia cells

Hideyuki Ikeuchi, Yong‐Mo Ahn, Takuya Otokawa et al. · Bioorganic & Medicinal Chemistry · 2012 · 46 citations · Full text

, , +10

DNA-Dependent Binding of Nargenicin to DnaE1 Inhibits Replication in <i>Mycobacterium tuberculosis</i>

Melissa D. Chengalroyen, Mandy K. Mason, Alessandro Borsellini et al. · ACS Infectious Diseases · 2022 · 23 citations · Full text

Targeting Mycobacterium tuberculosis response to environmental cues for the development of effective antitubercular drugs

Richard C. Lavin, Calvin M. Johnson, Yong‐Mo Ahn et al. · PLoS Biology · 2021 · 21 citations · Full text

Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD+) synthetase inhibitors as potential antitubercular agents

Xu Wang, Yong‐Mo Ahn, Adam G. Lentscher et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 20 citations · Full text

, , +9

Redesign of Rifamycin Antibiotics to Overcome ADP‐Ribosylation‐Mediated Resistance

Tian Lan, Uday S. Ganapathy, Sachin Sharma et al. · Angewandte Chemie International Edition · 2022 · 20 citations · Full text

, , +17

Rows per page

1–5 of 6